SavedAdd your journal

Journals / Türk Jinekoloji ve Obstetrik Derneği Dergisi / 2011 / Cilt: 8 - Sayı: 1

Evidence based approach to recurrent miscarriage

Tekrarlayan gebelik kayıplarına kanıta dayalı yaklaşım

Ayşe SEYHAN
Bülent URMAN
Barış ATA
Pages
5–20
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review we will discuss the prognosis and evidence-based aproach to diagnosis and treatment of recurrent miscarriage.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Recurrent miscarriage, defined as three or more consecutive misscarriages, affects approximately 0.5-1% of couples trying to have a child.
📊
Key Findings & Data:Genetic and uterine abnormalities, thrombophilias, environmental, endocrinologic and immunologic factors have been proposed to play a role in the etiology of recurrent miscarriage.
💡
Conclusion & Impact:In this review we will discuss the prognosis and evidence-based aproach to diagnosis and treatment of recurrent miscarriage.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Recurrent miscarriage, defined as three or more consecutive misscarriages, affects approximately 0.5-1% of couples trying to have a child. Genetic and uterine abnormalities, thrombophilias, environmental, endocrinologic and immunologic factors have been proposed to play a role in the etiology of recurrent miscarriage. The underlying pathology remains unidentified in aproximately half of the recurrent miscarriage patients. Couples’ expectations for a treatment often causes physicians to employ empiric treatments. In this review we will discuss the prognosis and evidence-based aproach to diagnosis and treatment of recurrent miscarriage.

Özet

Gebelik planlayan kadınların yaklaşık %0.5-1’i üç veya daha fazla ardışık gebelik kaybı yaşamaktadır. Etiyolojide genetik anormallikler, uterin patolojiler, trombofili, çevresel faktörler, endokrinolojik ve immünulojik nedenler rol oynayabilir.Tüm bu faktörler araştırılsa da hastaların yaklaşık yarısında herhangi bir neden ortaya konulamamaktadır. Açıklanamayan tekrarlayan gebelik kayıpları olan hastalar tedavi beklentisi içinde olduğundan, hekimler ampirik tedavi alternatiflerine sık sık başvurmaktadır. Bu derlemede, tekrarlayan gebelik kayıplarının prognozu, tanı ve tedavi yöntemleri mevcut kanıtlar ışığında tartışılacaktır.

🔖

Cite This Article

SEYHAN, A., URMAN, B., ATA, B. (2022). Evidence based approach to recurrent miscarriage. Türk Jinekoloji ve Obstetrik Derneği Dergisi, Cilt: 8 - Sayı: 1, 5–20. https://ajindex.com/articles/631611

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Stirrat GM. Recurrent miscarriage. Lancet 1990; 336: 673-5
  2. Farquharson RG, Jauniaux E, and Exalto N. Updated and revised nomenclature for description of early pregnancy events. Hum Reprod 2005; 20: 3008- 11
  3. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, and Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ 2000; 320: 1708- 12
  4. Salat-Baroux J. [Recurrent spontaneous abortions]. Reprod Nutr Dev 1988; 28: 1555- 68
  5. Porter TF and Scott JR. Evidence-based care of recurrent miscarriage. Best Pract Res Clin Obstet Gynaecol 2005; 19: 85- 101
  6. Christiansen OB. Epidemiology of recurrent pregnancy loss, in Carp H., Editor. Recurrent pregnancy loss. Causes, controversies and treatment, Informa healthcare. 2007: 1 - 13
  7. Christiansen O, Astrid M, and Nielsen H. Secondary Recurrent Miscarriage - A Unique Entity with Respect to Etiology and Treatment Current Women's Health Reviews 2006; 2: 119- 24
  8. Christiansen OB, Pedersen B, Nielsen HS, and Nybo Andersen AM. Impact of the sex of first child on the prognosis in secondary recurrent miscarriage. Hum Reprod 2004; 19: 2946- 51
  9. Goldenberg RL, Mayberry SK, Copper RL, Dubard MB, and Hauth JC. Pregnancy outcome following a second-trimester loss. Obstet Gynecol 1993; 81: 444- 6
  10. Oyen N, Skjaerven R, and Irgens LM. Population-based recurrence risk of sudden infant death syndrome compared with other infant and fetal deaths. Am J Epidemiol 1996; 144: 300- 5
  11. Clifford K, Rai R, and Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod 1997; 12: 387- 9
  12. Carp H, Toder V, Aviram A, Daniely M, Mashiach S, and Barkai G. Karyotype of the abortus in recurrent miscarriage. Fertil Steril 2001; 75: 678- 82
  13. Clark P, Brennand J, Conkie JA, McCall F, Greer IA, and Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 1166- 70
  14. Kjellberg U, Andersson NE, Rosen S, Tengborn L, and Hellgren M. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999; 81: 527- 31
  15. Brenner B. Inherited thrombophilia and pregnancy loss. Thromb Haemost 1999; 82: 634- 40
  16. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9- 13
  17. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe